HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation

por Nural-Guvener, Hikmet F, Zakharova, Luidmila, Nimlos, James, Popovic, Snjezana, Mastroeni, Diego, Gaballa, Mohamed A
Publicado 2014